These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27789667)

  • 1. Metabolic profiling-multitude of technologies with great research potential, but (when) will translation emerge?
    Ala-Korpela M; Davey Smith G
    Int J Epidemiol; 2016 Oct; 45(5):1311-1318. PubMed ID: 27789667
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolomics, nutrition and why epidemiology matters.
    Ebrahim S
    Int J Epidemiol; 2016 Oct; 45(5):1307-1310. PubMed ID: 27892407
    [No Abstract]   [Full Text] [Related]  

  • 3. Opening up the "Black Box": metabolic phenotyping and metabolome-wide association studies in epidemiology.
    Bictash M; Ebbels TM; Chan Q; Loo RL; Yap IK; Brown IJ; de Iorio M; Daviglus ML; Holmes E; Stamler J; Nicholson JK; Elliott P
    J Clin Epidemiol; 2010 Sep; 63(9):970-9. PubMed ID: 20056386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies.
    Würtz P; Kangas AJ; Soininen P; Lawlor DA; Davey Smith G; Ala-Korpela M
    Am J Epidemiol; 2017 Nov; 186(9):1084-1096. PubMed ID: 29106475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on Data Analysis in Metabolomics: Points of Agreement and Disagreement from the 2018 ASMS Fall Workshop.
    Baker ES; Patti GJ
    J Am Soc Mass Spectrom; 2019 Oct; 30(10):2031-2036. PubMed ID: 31440979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research.
    Emwas AH
    Methods Mol Biol; 2015; 1277():161-93. PubMed ID: 25677154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR and MS Methods for Metabolomics.
    Amberg A; Riefke B; Schlotterbeck G; Ross A; Senn H; Dieterle F; Keck M
    Methods Mol Biol; 2017; 1641():229-258. PubMed ID: 28748468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence?
    Lawlor DA; Davey Smith G; Kundu D; Bruckdorfer KR; Ebrahim S
    Lancet; 2004 May; 363(9422):1724-7. PubMed ID: 15158637
    [No Abstract]   [Full Text] [Related]  

  • 9. The Consortium of Metabolomics Studies (COMETS): Metabolomics in 47 Prospective Cohort Studies.
    Yu B; Zanetti KA; Temprosa M; Albanes D; Appel N; Barrera CB; Ben-Shlomo Y; Boerwinkle E; Casas JP; Clish C; Dale C; Dehghan A; Derkach A; Eliassen AH; Elliott P; Fahy E; Gieger C; Gunter MJ; Harada S; Harris T; Herr DR; Herrington D; Hirschhorn JN; Hoover E; Hsing AW; Johansson M; Kelly RS; Khoo CM; Kivimäki M; Kristal BS; Langenberg C; Lasky-Su J; Lawlor DA; Lotta LA; Mangino M; Le Marchand L; Mathé E; Matthews CE; Menni C; Mucci LA; Murphy R; Oresic M; Orwoll E; Ose J; Pereira AC; Playdon MC; Poston L; Price J; Qi Q; Rexrode K; Risch A; Sampson J; Seow WJ; Sesso HD; Shah SH; Shu XO; Smith GCS; Sovio U; Stevens VL; Stolzenberg-Solomon R; Takebayashi T; Tillin T; Travis R; Tzoulaki I; Ulrich CM; Vasan RS; Verma M; Wang Y; Wareham NJ; Wong A; Younes N; Zhao H; Zheng W; Moore SC
    Am J Epidemiol; 2019 Jun; 188(6):991-1012. PubMed ID: 31155658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Realising the potential of metabolomics.
    Nicholls AW
    Bioanalysis; 2012 Sep; 4(18):2195-7. PubMed ID: 23046260
    [No Abstract]   [Full Text] [Related]  

  • 11. The ABRF Metabolomics Research Group 2013 Study: Investigation of Spiked Compound Differences in a Human Plasma Matrix.
    Cheema AK; Asara JM; Wang Y; Neubert TA; Tolstikov V; Turck CW
    J Biomol Tech; 2015 Sep; 26(3):83-9. PubMed ID: 26290656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Applications of Metabolomics in Clinical Pharmacology.
    Pang H; Jia W; Hu Z
    Clin Pharmacol Ther; 2019 Sep; 106(3):544-556. PubMed ID: 31173340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.
    Lawlor DA; Harbord RM; Sterne JA; Timpson N; Davey Smith G
    Stat Med; 2008 Apr; 27(8):1133-63. PubMed ID: 17886233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated genomics and metabolomics in nephrology.
    Atzler D; Schwedhelm E; Zeller T
    Nephrol Dial Transplant; 2014 Aug; 29(8):1467-74. PubMed ID: 24366899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in metabolic profiling.
    Barrett D
    Bioanalysis; 2012 Mar; 4(6):643-4. PubMed ID: 22452253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and analysis of metabolomics studies in epidemiologic research: a primer on -omic technologies.
    Tzoulaki I; Ebbels TM; Valdes A; Elliott P; Ioannidis JP
    Am J Epidemiol; 2014 Jul; 180(2):129-39. PubMed ID: 24966222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical applications of metabolomics in oncology: a review.
    Spratlin JL; Serkova NJ; Eckhardt SG
    Clin Cancer Res; 2009 Jan; 15(2):431-40. PubMed ID: 19147747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR and MS methods for metabonomics.
    Dieterle F; Riefke B; Schlotterbeck G; Ross A; Senn H; Amberg A
    Methods Mol Biol; 2011; 691():385-415. PubMed ID: 20972767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of metabolomics in human gut microbiota research.
    Smirnov KS; Maier TV; Walker A; Heinzmann SS; Forcisi S; Martinez I; Walter J; Schmitt-Kopplin P
    Int J Med Microbiol; 2016 Aug; 306(5):266-279. PubMed ID: 27012595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomics: a revolution for novel cancer marker identification.
    Bu Q; Huang Y; Yan G; Cen X; Zhao YL
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):266-75. PubMed ID: 22221059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.